SCHEMBL611683

SCHEMBL611683

Oc1ccc2c(c1O)CC(c1ccccc1)C1CCNCC21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 10/20 1.00
DRD2 P14416 5/20 1.00
DRD5 P21918 2/20 1.00
ADRA2A P08913 1/20 1.00
ADRA2B P18089 1/20 1.00
ADRA2C P18825 1/20 1.00
DRD3 P35462 1/20 1.00
MAPT P10636 3/20 0.41
KDM4E B2RXH2 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PKM P14618 2/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952930 0.88 ADRA2A (0.78) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952932 0.81 ADRA2A (0.68) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952996 0.79 DRD1 (0.65) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952994 0.79 ADRA2A (0.65) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22953002 0.79 ADRA2A (0.65) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952992 0.79 DRD1 (0.65) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952936 0.78 DRD1 (0.63) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952993 0.77 ADRA2A (0.62) DRD1DRD2DRD5ADRA2AADRA2B
SCHEMBL22952931 0.75 DRD1 (0.60) DRD1DRD2DRD5ADRA2AADRA2B
Hydrochloric Acid SCHEMBL612977 0.75 ADRA2A (0.60) DRD1DRD2DRD5ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359303-B2 Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor PURDUE RESEARCH FOUNDATION (US) 2016-06-07 US claimed
US-9359303-B2 Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor PURDUE RESEARCH FOUNDATION (US) 2016-06-07 US disclosed
EP-2421862-B1 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR PURDUE RESEARCH FOUNDATION (US) 2014-06-11 EP disclosed
US-20120041018-A1 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR PURDUE RESEARCH FOUNDATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041018-A1 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR DBH, SLC6A3, SLC18A2 DRD1 49/4885DRD2 8/4885DRD5 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.